SCN8A and Alzheimer disease: Further, it was observed that soluble Aβ exposure selectively upregulated the expression and function of Nav1.6 [29] and that pyramidal cell hyperactivity was abolished following treatment with Nav channel blockers [94], implicating this Nav channel isoform as a driver of AD-related hyperactivity.